
About this product
A peptide serum formulated with a bio-engineered growth factor complex designed to support skin firmness, texture, and overall quality without human-derived growth factors.
Best for
Type
Key actives
Formula notes
Full ingredients
Guru Score
Approved
9 experts · Strong agreementWhat the gurus are saying
The serum's peptide and growth factor blend earns broad praise for stimulating collagen and elastin production, which gurus say can speed up skin cell turnover and improve texture. Most reviewers call it lightweight and hydrating with a pleasant feel, and dermatologists note it's a strong choice for those already familiar with retinoids and entry-level peptides who want to try a more advanced option at a fraction of the price of competitors. One reviewer found it insufficiently hydrating and didn't see results, though most suggest it works best paired with a moisturizer.
Every take we've logged from this product's reviews across YouTube. Click any row to watch the moment they said it.
A peptide serum formulated with a bio-engineered growth factor complex designed to support skin firmness, texture, and overall quality without human-derived growth factors.
Mostly yes. 7 of the 9 gurus who reviewed it give it their stamp of approval, for a Guru Score of 78%.
DRMTLGY Needleless Growth Factor Serum holds a Guru Score of 78%. That is our read on how warmly the experts talk about it, based on the verdicts of 9 independent expert reviewers we have collected. At least one expert has named it a Top Pick in its category.
DRMTLGY Needleless Growth Factor Serum is generally suited to mature skin.
Lower-priced serums the gurus still rate highly, versus this mid-range pick.
See how they stack up →Other products the same gurus have weighed in on, plus more from this brand and category.
Compare side by side →Stories where our editors dug into this product or its brand.
A weekly read of the takes worth catching up on: the raves, the splits, the ones the gurus won't shut up about. Free, no spam, unsubscribe whenever.
Subscribe to the digest